by Hannah Mongeon | Jul 1, 2020 | Blog
And is your company prepared for what may be coming next? As biotech and pharmaceutical companies work to stabilize their clinical programs and business strategies during the significant disruptions caused by the COVID-19 pandemic, one of the potential challenges that...
by Hannah Mongeon | Jun 4, 2020 | Blog
As a communications agency serving the biotech, pharmaceutical, and affiliated health science industry for over 20 years, LaVoieHealthScience has developed specific guidance for clients on how to develop and deliver highly effective corporate presentations. As a...
by Ben Beyer | Feb 10, 2020 | Blog
Start reaching out if you have not already to top targetsSpread a wide net. Extend your reach and target 20% or more new names. 2x outreach + personal emails. Master schedule, one pen. 30 min meetings; 15 min travel timeTry BIO’s 1×1 meeting platform or...
by Ben Beyer | Feb 9, 2020 | Blog
The EU’s signature framework for the financial markets is starting to have major impacts in the US What are the challenges and potential opportunities for companies in the life sciences? On January 3, 2018 the Market in Financial Instruments Directive (MiFID) II was...
by Ben Beyer | Feb 8, 2020 | Blog
LinkedIn is a critical tool for networking, branding, and showcasing the talent that makes your team unique. With a growing number of life science professionals on LinkedIn, your company’s presence on the platform can serve as a point of reference for investors,...
by Ben Beyer | Feb 7, 2020 | Blog
How you tell your company’s story before, during and after an IPO can have a big impact on your valuation and market success Preparing for an IPO signs you and your company up for months of hard strategizing, messaging and decision-making to effectively tap the...
Recent Comments